Class-Action Suit Against Pfizer Over Anti-Smoking Drug Champix Will Proceed

barbara.lempert OTTAWA, Canada, July 26, 2013 (CANADIAN PRESS DATAFILE) – A class-action lawsuit against pharmaceutical giant Pfizer Canada over its anti-smoking drug ...

Perrigo to take over Elan for $8.6 billion

Ryan McBride FierceBiotech News

Blue Cross Blue Shield of Michigan saves an estimated $155 million over three years from Patient-Centered Medical Home program

barbara.lempert Largest PCMH program in the nation yields improvements in quality and preventive care DETROIT, July 8, 2013 /PRNewswire/ — Blue Cross Blue Shield of Michigan ...

FDA Loses Case Over Execution Drug; Will Shortages Be Effected?

esilverman In a blow to the FDA, a three-judge appeals court panel has ruled unanimously that the agency violated federal law by allowing several states to import thiopental ...

Celgene Halts Revlimid Trial Over Patient Deaths, Prompting Investor Anxiety

esilverman In a setback to expanding the market for its flagship drug, Celgene has ended a Phase III trial of Revlimid, which was being tested in elderly patients with a type ...

WellPoint pays HHS $1.7 million for leaving information accessible over Internet

barbara.lempert The managed care company WellPoint Inc. has agreed to pay the U.S. Department of Health and Human Services (HHS) $ 1.7 million to settle potential violations of the ...

Feds Probe Novartis Over Marketing Of Its Gilenya MS Pill

esilverman YOU READ IT HERE FIRST: Novartis marketing is under a microscope. The US Attorney in New York has issued a civil investigative demand to the drugmaker for documents ...

After Eylea win, Regeneron Pharma execs puzzle over R&D scale-up challenge

Ryan McBride With a new blockbuster drug and more potential hits in development, Regeneron Pharmaceuticals has been successful long enough for top executives to consider the challenges ...

J&J Pays $23M To Settle Class Action Suit Over OTC Troubles

esilverman For the past year, Johnson & Johnson execs have been saying that the cost to get their troubled Fort Washington, Pennsylvania plant, which was the scene of numerous ...

FDA Warns Genentech Trial Investigator Over Data Problems

esilverman An investigator for a Phase III trial for the Lucentis macular degeneration treatment, which is sold by Genentech, has received a warning letter from the FDA for ...

Clinical Trials Slow In India Amid Debate Over Patient Safety

esilverman Now that the Indian government has adopted new rules for clinical trials, drugmakers and contract research organizations are reacting by slowing the pace of studies ...

Indian Regulator Challenges J&J Over Baby Product Ads

esilverman In another challenge by Indian officials to Johnson & Johnson, the Maharashtra government in western India has issued a show cause order to the health care giant ...
Page 5 of 8« First...34567...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS